09:45 EDT Sonnet Biotherapeutics (SONN) Holdings Inc trading resumes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONN:
- Sonnet says SON-1010 demonstrates ‘strong safety profile’ in atezolizumab combo
- Sonnet Biotherapeutics Holdings Inc trading halted, news pending
- Sonnet BioTherapeutics Announces New Interim CEO Appointment
- Sonnet BioTherapeutics announces passing of founder, CEO Pankaj Mohan
- Sonnet BioTherapeutics completes first safety review of SON-1010